Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Pivotal role of mTOR signaling in hepatocellular carcinoma.

Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM.

Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11. doi: 10.1053/j.gastro.2008.08.008. Epub 2008 Aug 20.

2.

Molecular targeted therapies in hepatocellular carcinoma.

Llovet JM, Bruix J.

Hepatology. 2008 Oct;48(4):1312-27. doi: 10.1002/hep.22506. Review.

3.

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.

Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Solé M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet JM.

Cancer Res. 2008 Aug 15;68(16):6779-88. doi: 10.1158/0008-5472.CAN-08-0742.

4.

Sorafenib in advanced hepatocellular carcinoma.

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group.

N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.

5.

Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.

Georgiades CS, Hong K, Geschwind JF.

Cancer J. 2008 Mar-Apr;14(2):117-22. doi: 10.1097/PPO.0b013e31816a0fac.

PMID:
18391617
6.

Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1.

Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB.

Cancer Res. 2008 Mar 1;68(5):1478-84. doi: 10.1158/0008-5472.CAN-07-6164.

7.

Cancer statistics, 2008.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ.

CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96. doi: 10.3322/CA.2007.0010. Epub 2008 Feb 20.

8.

Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.

Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR.

Cell. 2008 Feb 8;132(3):363-74. doi: 10.1016/j.cell.2007.12.032.

9.

Biology of hepatocellular carcinoma.

Pang RW, Joh JW, Johnson PJ, Monden M, Pawlik TM, Poon RT.

Ann Surg Oncol. 2008 Apr;15(4):962-71. doi: 10.1245/s10434-007-9730-z. Epub 2008 Jan 31. Review.

PMID:
18236113
10.

Sorafenib: in hepatocellular carcinoma.

Simpson D, Keating GM.

Drugs. 2008;68(2):251-8. Review.

PMID:
18197728
11.

Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.

O'Neil BH, Venook AP.

Oncologist. 2007 Dec;12(12):1425-32. doi: 10.1634/theoncologist.12-12-1425. Review.

12.

Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling.

Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB.

Oncogene. 2008 Feb 14;27(8):1114-21. Epub 2007 Aug 20.

PMID:
17704808
13.
14.

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

El-Serag HB, Rudolph KL.

Gastroenterology. 2007 Jun;132(7):2557-76. Review.

PMID:
17570226
15.

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.

Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Place RF, Pookot D, Majid S, Igawa M, Dahiya R.

Oncogene. 2007 Dec 6;26(55):7647-55. Epub 2007 Jun 11.

PMID:
17563745
16.

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.

Sarkar D, Lebedeva IV, Su ZZ, Park ES, Chatman L, Vozhilla N, Dent P, Curiel DT, Fisher PB.

Cancer Res. 2007 Jun 1;67(11):5434-42.

17.

Genetics of hepatocellular carcinoma.

Teufel A, Staib F, Kanzler S, Weinmann A, Schulze-Bergkamen H, Galle PR.

World J Gastroenterol. 2007 Apr 28;13(16):2271-82. Review.

18.

WNT/beta-catenin signaling in liver health and disease.

Thompson MD, Monga SP.

Hepatology. 2007 May;45(5):1298-305. Review.

PMID:
17464972
19.

Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration.

Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, Bruce JN, Volsky DJ, Fisher PB.

Pharmacol Ther. 2007 May;114(2):155-70. Epub 2007 Feb 24. Review. Erratum in: Pharmacol Ther. 2007 Jul;115(1):176.

20.

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM.

Hepatology. 2007 Apr;45(4):938-47.

PMID:
17393520

Supplemental Content

Support Center